drug-regulation
Every record this desk has filed under drug-regulation, newest first, each with the number of sources it can still show you.
HHS announces draft enforcement discretion for certain peptide compounding, without granting drug approval
An October 30 Federal Register notice announces a draft HHS enforcement policy for compounding with certain peptide bulk drug substances while a regulatory list is developed. The notice says compounded drugs are not FDA-approved and the draft is not binding. It invites comments for two weeks after publication, but the linked policy appendix could not be read.
Also filed underhealthcompoundingpeptidespublic-comments
A record appears here because it carries drug-regulation in its own tags. If a record you expected is missing, it was filed under a different subject — the full list is on the topics index.